从致病性抗体中去除"味道"可以达到治疗性甜点
Dana L E Vergoossen1, Maartje G Huijbers1,2
1Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
Science immunology
|December 6, 2024
概括
内葡萄糖酶CU43是一种酶,可以从免疫球蛋白G (IgG) 抗体中去除特定的糖链. 在各种模型中,这种作用抑制了免疫反应,并减少了疾病的严重程度.
科学领域:
- 葡萄糖生物学 葡萄糖生物学
- 免疫学 免疫学 免疫学
- 酶学 是一种酶学.
背景情况:
- 免疫球蛋白G (IgG) 抗体在免疫反应中发挥着核心作用.
- IgG Fc域的糖化显著影响其效应器功能和与Fc受体的相互作用.
- 异常的IgG糖化与各种自身免疫和炎症性疾病有关.
研究的目的:
- 为了研究Endoglycosidase CU43对IgG Fc glycans的酶活性.
- 为了确定CU43介导的脱糖化对IgG效应器功能的影响.
- 在临床前疾病模型中评估Endoglycosidase CU43的治疗潜力.
主要方法:
- 纯化和表征Endoglycosidase CU43.3 的特性.
- 用CU43.3对纯化人类IgG进行酶处理.
- 使用质谱测量评估IgG Fc甘氨酸结构.
- 在体外测试测量IgG与Fc受体的结合以及抗体依赖细胞毒性 (ADCC).
- 在已建立的自身免疫和炎症疾病模型中进行体内研究.
主要成果:
- 内葡萄糖酶CU43有效地从IgG Fc域中去除关键的N链 glycans.
- 通过CU43的脱糖化取消了IgG与激活Fc玛受体 (FcγRs) 的结合.
- CU43治疗显著抑制FcγR介导的效应因子功能,包括ADCC和细胞因子释放.
- 用Endoglycosidase CU43改善了多种疾病模型中的病理和临床症状,包括关节炎和狼模型.
结论:
- 内葡萄糖酶CU43是一种强大的酶,用于降糖化IgG抗体.
- 通过CU43去除IgG Fc甘氨酸,有效地抑制有害的免疫反应.
- 内葡萄糖酶CU43代表了对IgG介导疾病的有前途的治疗策略.
更多相关视频
相关概念视频
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Affinity and Avidity
35.8K
Overview
35.8K
Humoral Immune Responses
71.5K
Overview
71.5K
Immune Response Against Viral Pathogens
748
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
748
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


